Analysen zu Novo Nordisk
| 08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.03.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.03.25 | Novo Nordisk Buy | UBS AG | |
| 17.03.25 | Novo Nordisk Buy | UBS AG | |
| 14.03.25 | Novo Nordisk Buy | UBS AG | |
| 12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.03.25 | Novo Nordisk Buy | UBS AG | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.02.25 | Novo Nordisk Market-Perform | Bernstein Research |
Aktuelle Aktienanalysen
| 29.01.26 | Fresenius Buy | Deutsche Bank AG | |
| 29.01.26 | GEA Buy | UBS AG | |
| 29.01.26 | ASML NV Buy | Deutsche Bank AG | |
| 29.01.26 | AUTO1 Buy | Deutsche Bank AG | |
| 29.01.26 | Airbus Buy | Deutsche Bank AG | |
| 29.01.26 | flatexDEGIRO Buy | Deutsche Bank AG | |
| 29.01.26 | KRONES Buy | Deutsche Bank AG | |
| 29.01.26 | Siemens Energy Buy | Deutsche Bank AG | |
| 29.01.26 | Volvo AB Hold | Deutsche Bank AG | |
| 29.01.26 | Daimler Truck Buy | Jefferies & Company Inc. | |
| 29.01.26 | Microsoft Buy | Jefferies & Company Inc. | |
| 29.01.26 | Siemens Energy Buy | UBS AG | |
| 29.01.26 | Meta Platforms Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | ABB Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | Nokia Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | easyJet Underweight | JP Morgan Chase & Co. | |
| 29.01.26 | Microsoft Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Nemetschek Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Nokia Neutral | UBS AG | |
| 29.01.26 | Sanofi Neutral | UBS AG | |
| 29.01.26 | OMV Underperform | RBC Capital Markets | |
| 29.01.26 | Deutsche Bank Buy | UBS AG | |
| 29.01.26 | DWS Group Neutral | UBS AG | |
| 29.01.26 | Givaudan Neutral | UBS AG | |
| 29.01.26 | ING Group Buy | UBS AG | |
| 29.01.26 | SAP Buy | UBS AG | |
| 29.01.26 | Nordea Bank Abp Registered Shs Buy | Jefferies & Company Inc. | |
| 29.01.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 29.01.26 | Roche Underperform | Jefferies & Company Inc. | |
| 29.01.26 | Sanofi Buy | Jefferies & Company Inc. | |
| 29.01.26 | ING Group Hold | Jefferies & Company Inc. | |
| 29.01.26 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 29.01.26 | ABB Hold | Jefferies & Company Inc. | |
| 29.01.26 | Nokia Buy | Jefferies & Company Inc. | |
| 29.01.26 | DWS Group Hold | Jefferies & Company Inc. | |
| 29.01.26 | Deutsche Bank Hold | Jefferies & Company Inc. | |
| 29.01.26 | ASML NV Outperform | Bernstein Research | |
| 29.01.26 | SAP Buy | Jefferies & Company Inc. | |
| 29.01.26 | LVMH Moet Hennessy Louis Vuitton Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.26 | STMicroelectronics Buy | Jefferies & Company Inc. | |
| 29.01.26 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Deutsche Bank Hold | Warburg Research | |
| 29.01.26 | Microsoft Outperform | RBC Capital Markets | |
| 29.01.26 | Deutsche Bank Outperform | RBC Capital Markets | |
| 29.01.26 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | ASML NV Buy | Goldman Sachs Group Inc. | |
| 29.01.26 | Meta Platforms Buy | UBS AG | |
| 29.01.26 | SAP Buy | Goldman Sachs Group Inc. | |
| 29.01.26 | ASML NV Overweight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.